GT Biopharma, Inc. GTBP
GTBP
GT Biopharma, Inc. ARTL
Artelo Biosciences, Inc. PTIX
Protagenic Therapeutics, Inc. CARM
Carisma Therapeutics, Inc. SLRX
Salarius Pharmaceuticals, Inc. WINT
Windtree Therapeutics, Inc. PBM
Psyence Biomedical Ltd. SLXN
Silexion Therapeutics Ltd. LIPO
Lipella Pharmaceuticals Inc. DRMA
Dermata Therapeutics, Inc.
GT Biopharma, Inc. ARTL
Artelo Biosciences, Inc. PTIX
Protagenic Therapeutics, Inc. CARM
Carisma Therapeutics, Inc. SLRX
Salarius Pharmaceuticals, Inc. WINT
Windtree Therapeutics, Inc. PBM
Psyence Biomedical Ltd. SLXN
Silexion Therapeutics Ltd. LIPO
Lipella Pharmaceuticals Inc. DRMA
Dermata Therapeutics, Inc.
Performance
| Periode | GTBP | ARTL | PTIX | CARM | SLRX | WINT | PBM | SLXN | LIPO | DRMA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -75.89 % | -72.28 % | -65.27 % | -90.46 % | -95.77 % | -90.00 % | -81.32 % | -79.66 % | -81.73 % | 249.68 % |
| YTD | -73.68 % | -75.08 % | -82.94 % | -90.23 % | -97.45 % | -99.76 % | -93.76 % | -91.66 % | -93.68 % | 58.99 % |
| 1Y | -72.46 % | -71.70 % | -83.42 % | -88.92 % | -97.17 % | -99.75 % | -94.55 % | -93.44 % | -93.52 % | 79.67 % |
| 3Y | -97.63 % | -90.63 % | -94.32 % | -99.58 % | -99.54 % | -100.00 % | -99.98 % | -99.05 % | -99.37 % | -94.94 % |
| 5Y | -99.77 % | -97.26 % | -99.02 % | -99.83 % | -99.97 % | -100.00 % | -99.98 % | -99.05 % | -96.50 % | -99.82 % |
| 10Y | -100.00 % | -99.61 % | -99.02 % | -99.93 % | -100.00 % | -100.00 % | -99.98 % | -99.05 % | -96.50 % | -99.82 % |
| From the beginning | -100.00 % | -99.61 % | -99.02 % | -99.98 % | -100.00 % | -100.00 % | -99.98 % | -99.05 % | -96.50 % | -99.82 % |